Rohto Pharmaceutical Co.,Ltd. (TYO: 4527)
Japan
· Delayed Price · Currency is JPY
3,571.00
-16.00 (-0.45%)
Oct 10, 2024, 10:04 AM JST
Rohto Pharmaceutical Co.,Ltd. Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Cash & Equivalents | 73,623 | 89,210 | 79,951 | 72,791 | 52,964 | 45,307 | Upgrade
|
Cash & Short-Term Investments | 73,623 | 89,210 | 79,951 | 72,791 | 52,964 | 45,307 | Upgrade
|
Cash Growth | -5.71% | 11.58% | 9.84% | 37.43% | 16.90% | 19.68% | Upgrade
|
Receivables | 67,524 | 69,115 | 60,656 | 51,682 | 47,865 | 50,416 | Upgrade
|
Inventory | 59,798 | 46,657 | 41,062 | 33,527 | 27,925 | 30,625 | Upgrade
|
Other Current Assets | 10,742 | 9,777 | 8,577 | 6,306 | 4,317 | 3,760 | Upgrade
|
Total Current Assets | 211,687 | 214,759 | 190,246 | 164,306 | 133,071 | 130,108 | Upgrade
|
Property, Plant & Equipment | 83,716 | 68,607 | 66,182 | 62,839 | 49,790 | 48,460 | Upgrade
|
Long-Term Investments | 48,282 | 43,731 | 32,629 | 27,471 | 27,425 | 24,024 | Upgrade
|
Goodwill | 47,992 | 2,285 | 2,564 | 2,954 | 4,014 | 3,373 | Upgrade
|
Other Intangible Assets | 8,557 | 6,932 | 6,997 | 6,338 | 3,521 | 1,945 | Upgrade
|
Long-Term Deferred Tax Assets | - | 3,869 | 5,371 | 5,297 | 4,606 | 4,292 | Upgrade
|
Other Long-Term Assets | 8,497 | 2 | 1 | 2 | 2 | 2 | Upgrade
|
Total Assets | 408,731 | 346,175 | 309,677 | 274,627 | 225,790 | 215,301 | Upgrade
|
Accounts Payable | 21,182 | 21,123 | 18,718 | 16,269 | 11,330 | 14,243 | Upgrade
|
Accrued Expenses | 23,213 | 25,720 | 24,362 | 19,354 | 25,208 | 28,312 | Upgrade
|
Short-Term Debt | 26,538 | 5,304 | 4,177 | 8,033 | 2,312 | 2,105 | Upgrade
|
Current Income Taxes Payable | 4,077 | 6,643 | 6,230 | 3,185 | 6,138 | 5,728 | Upgrade
|
Other Current Liabilities | 44,526 | 28,297 | 26,675 | 24,647 | 11,483 | 11,729 | Upgrade
|
Total Current Liabilities | 119,536 | 87,087 | 80,162 | 71,488 | 56,471 | 62,117 | Upgrade
|
Long-Term Debt | 19,332 | 5,190 | 7,516 | 13,350 | 5,787 | 5,190 | Upgrade
|
Long-Term Deferred Tax Liabilities | - | 1,597 | 1,173 | 1,450 | 639 | 373 | Upgrade
|
Other Long-Term Liabilities | 9,888 | 2,720 | 2,645 | 1,177 | 2,831 | 3,274 | Upgrade
|
Total Liabilities | 151,485 | 99,142 | 94,600 | 90,797 | 69,179 | 75,271 | Upgrade
|
Common Stock | 6,504 | 6,504 | 6,504 | 6,504 | 6,504 | 6,504 | Upgrade
|
Additional Paid-In Capital | 3,071 | 4,516 | 5,292 | 5,787 | 5,661 | 5,661 | Upgrade
|
Retained Earnings | 214,749 | 209,399 | 184,005 | 162,195 | 145,511 | 131,985 | Upgrade
|
Treasury Stock | -4,939 | -4,939 | -4,938 | -4,936 | -4,936 | -4,935 | Upgrade
|
Comprensive Income & Other | 38,398 | 30,843 | 18,706 | 8,737 | 3,167 | 66 | Upgrade
|
Total Common Equity | 257,783 | 246,323 | 209,569 | 178,287 | 155,907 | 139,281 | Upgrade
|
Minority Interest | -537 | 710 | 5,508 | 5,543 | 704 | 749 | Upgrade
|
Shareholders' Equity | 257,246 | 247,033 | 215,077 | 183,830 | 156,611 | 140,030 | Upgrade
|
Total Liabilities & Equity | 408,731 | 346,175 | 309,677 | 274,627 | 225,790 | 215,301 | Upgrade
|
Total Debt | 45,870 | 10,494 | 11,693 | 21,383 | 8,099 | 7,295 | Upgrade
|
Net Cash (Debt) | 27,753 | 78,716 | 68,258 | 51,408 | 44,865 | 38,012 | Upgrade
|
Net Cash Growth | -58.56% | 15.32% | 32.78% | 14.58% | 18.03% | 16.29% | Upgrade
|
Net Cash Per Share | 121.31 | 344.04 | 298.33 | 224.69 | 196.09 | 166.15 | Upgrade
|
Filing Date Shares Outstanding | 228.14 | 228.14 | 228.14 | 228.14 | 228.14 | 228.14 | Upgrade
|
Total Common Shares Outstanding | 228.14 | 228.14 | 228.14 | 228.14 | 228.14 | 228.14 | Upgrade
|
Working Capital | 92,151 | 127,672 | 110,084 | 92,818 | 76,600 | 67,991 | Upgrade
|
Book Value Per Share | 1129.94 | 1079.71 | 918.60 | 781.48 | 683.38 | 610.51 | Upgrade
|
Tangible Book Value | 201,234 | 237,106 | 200,008 | 168,995 | 148,372 | 133,963 | Upgrade
|
Tangible Book Value Per Share | 882.07 | 1039.31 | 876.69 | 740.75 | 650.35 | 587.20 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.